Immunohistochemical detection of prion protein in sheep with scrapie.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMID 8104039)

Published in J Vet Diagn Invest on July 01, 1993

Authors

J M Miller1, A L Jenny, W D Taylor, R F Marsh, R Rubenstein, R E Race

Author Affiliations

1: Virology Cattle Research Unit, USDA, Agricultural Research Service, Ames, IA 50010.

Articles by these authors

Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05

Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol (1994) 5.12

Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol (1992) 4.02

N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol (1991) 3.55

Natural infection of Suffolk sheep with scrapie virus. J Infect Dis (1982) 3.42

Diffusion of a small molecule in the cytoplasm of mammalian cells. Proc Natl Acad Sci U S A (1984) 3.41

Human papovavirus (JC): induction of brain tumors in hamsters. Science (1973) 3.05

Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00

Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80

Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol (1992) 2.55

Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol (1987) 2.54

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion (2000) 2.52

Phosphate concentrations in lakes. Nature (2000) 2.32

Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol (1989) 2.08

Characterization of Aleutian disease virus as a parvovirus. J Virol (1980) 2.04

Identification of a nonvirion protein of Aleutian disease virus: mink with Aleutian disease have antibody to both virion and nonvirion proteins. J Virol (1982) 2.02

Potent inhibition of scrapie-associated PrP accumulation by congo red. J Neurochem (1992) 2.00

Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev (1994) 2.00

Aleutian disease of mink: the antibody response of sapphire and pastel mink to Aleutian disease virus. J Immunol (1975) 1.95

Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol (1986) 1.95

The host range of chronic wasting disease is altered on passage in ferrets. Virology (1998) 1.95

Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet Pathol (1980) 1.88

Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol (1994) 1.85

In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J Gen Virol (1984) 1.80

Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology, and pathogenesis. J Infect Dis (1975) 1.79

Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun (1983) 1.77

Pathogenicity of West Nile virus in chickens. Avian Dis (2001) 1.76

Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents. J Gen Virol (1985) 1.75

Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues. Proc Natl Acad Sci U S A (1986) 1.75

Detection of scrapie-associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissue preparations. J Gen Virol (1986) 1.67

Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Virol (2000) 1.66

PrP genotypes of captive and free-ranging Rocky Mountain elk (Cervus elaphus nelsoni) with chronic wasting disease. J Gen Virol (1999) 1.64

Congo red inhibition of scrapie agent replication. J Virol (1993) 1.60

In situ molecular hybridization for detection of Aleutian mink disease parvovirus DNA by using strand-specific probes: identification of target cells for viral replication in cell cultures and in mink kits with virus-induced interstitial pneumonia. J Virol (1987) 1.56

Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology (1994) 1.50

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion (2001) 1.49

Impact of BDNF Val66Met and 5-HTTLPR polymorphism variants on neural substrates related to sadness and executive function. Genes Brain Behav (2012) 1.48

Characterization of the enzyme complex involving the folate-requiring enzymes of de novo purine biosynthesis. Biochemistry (1980) 1.48

Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families. Eur J Epidemiol (1991) 1.48

A preliminary report on the experimental host range of the transmissible mink encephalopathy agent. J Infect Dis (1969) 1.45

Partial purification and evidence for multiple molecular forms of the scrapie agent. Biochemistry (1978) 1.42

High dose metoclopramide-preliminary pharmacokinetic studies. Br J Clin Pharmacol (1983) 1.38

Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J (1997) 1.36

Intracerebral transmission of scrapie to cattle. J Infect Dis (1994) 1.36

Physical and chemical properties of the transmissible mink encephalopathy agent. J Virol (1969) 1.35

Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils. J Virol (1987) 1.35

Parvovirus infection in pigs with necrotic and vesicle-like lesions. Vet Microbiol (1985) 1.33

Passive transfer of antiviral antibodies restricts replication of Aleutian mink disease parvovirus in vivo. J Virol (1989) 1.32

The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol Aging (2001) 1.31

Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J Neurochem (2001) 1.30

Susceptibility of mink to sheep scrapie. Science (1971) 1.30

Analysis of Aleutian disease of mink parvovirus infection using strand-specific hybridization probes. Intervirology (1987) 1.29

Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines. J Gen Virol (1988) 1.28

Guidelines for treatment of onychomycosis. Br J Dermatol (2003) 1.27

Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J Virol (1990) 1.24

Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink. J Virol (1985) 1.21

Monoclonal antibodies against Aleutian disease virus distinguish virus strains and differentiate sites of virus replication from sites of viral antigen sequestration. J Virol (1986) 1.18

Comparative analysis of scrapie agent inactivation methods. J Virol Methods (1993) 1.18

Purification of the scrapie agent by density gradient centrifugation. J Gen Virol (1984) 1.13

Atypical keloids after dermabrasion of patients taking isotretinoin. J Am Acad Dermatol (1986) 1.12

Properties of the scrapie agent-endomembrane complex from hamster brain. J Virol (1976) 1.12

Transmissible mink encephalopathy: experimental transmission to the squirrel monkey. Science (1970) 1.12

Correlation of gamma-ray inactivation and strand scission in the replicative form of phi-X174 bacteriophage DNA. Proc Natl Acad Sci U S A (1967) 1.11

Mites as vectors for scrapie. Lancet (1996) 1.11

Liposuction for lipomas. J Dermatol Surg Oncol (1985) 1.10

Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update. Mol Biotechnol (1999) 1.10

Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience (2005) 1.10

Transmissible mink encephalopathy: studies on the peripheral lymphocyte. Infect Immun (1973) 1.09

Veterinary nurse training. Vet Rec (1992) 1.08

Aleutian disease virus, a parvovirus, is proteolytically degraded during in vivo infection in mink. J Virol (1984) 1.08

Temporal distribution of transmissible mink encephalopathy virus in mink inoculated subcutaneously. J Virol (1987) 1.08

Ischemic stroke associated with methamphetamine inhalation. Neurology (1988) 1.07

Detection of prion protein in formalin-fixed brain by hydrated autoclaving immunohistochemistry for the diagnosis of scrapie in sheep. J Vet Diagn Invest (1994) 1.07

Experimental infection of cattle with the agents of transmissible mink encephalopathy and scrapie. J Comp Pathol (1995) 1.07

Effects of fish and plankton and lake temperature and mixing depth. Science (1990) 1.07

Transmissible mink encephalopathy: neuroglial response. Am J Vet Res (1969) 1.06

In vitro expression in eukaryotic cells of a prion protein gene cloned from scrapie-infected mouse brain. Proc Natl Acad Sci U S A (1988) 1.04

Demonstration of scrapie strain diversity in infected PC12 cells. J Gen Virol (1992) 1.04

Transmissible mink encephalopathy species barrier effect between ferret and mink: PrP gene and protein analysis. J Gen Virol (1994) 1.04

Royal pastel mink respond variously to inoculation with Aleutian disease virus of low virulence. J Virol (1984) 1.04

Evidence for an essential DNA component in the Scrapie agent. Nature (1978) 1.04

Evidence of mitochondrial involvement in scrapie infection. J Virol (1989) 1.03

Experimental scrapie in the mouse: electrophoretic and sedimentation properties of the partially purified agent. J Neurochem (1980) 1.03

Acute African swine fever. Proliferative phase in lymphoreticular tissue and the reticuloendothelial system. Cornell Vet (1971) 1.03

Presence of mitochondrial D-loop DNA in scrapie-infected brain preparations enriched for the prion protein. J Virol (1990) 1.03

Characterization of Newcastle disease virus (avian paramyxovirus-1) isolated from pigeons. Avian Dis (1987) 1.01

Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. J Virol Methods (2000) 1.00

Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells. J Virol (1991) 1.00

Paired helical filaments associated with Alzheimer disease are readily soluble structures. Brain Res (1986) 1.00

Clinical and molecular genetic study of a large German kindred with Gerstmann-Sträussler-Scheinker syndrome. Neurology (1991) 0.99

Sedimentation characteristics of the scrapie agent from murine spleen and brain. Biochemistry (1978) 0.99

Inactivation of the scrapie agent by ultraviolet irradiation in the presence of chlorpromazine. J Gen Virol (1985) 0.99

Liver pathology in African swine fever. Cornell Vet (1971) 0.98

The search for scrapie agent nucleic acid. Microbiol Rev (1990) 0.97

Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. J Chromatogr A (1999) 0.97

Potomac horse fever agent in mice. Vet Rec (1985) 0.96